1. Mitochondrial dynamics as a potential therapeutic target in acute myeloid leukemia.
- Author
-
Kinoshita M, Saito Y, Otani K, Uehara Y, Nagasawa S, Nakagawa M, Yamada A, Kamimura S, and Moritake H
- Subjects
- Humans, Animals, Mice, Cell Line, Tumor, Cell Proliferation, Mitochondria metabolism, Quinazolinones pharmacology, Molecular Targeted Therapy, Membrane Proteins, Leukemia, Myeloid, Acute genetics, Leukemia, Myeloid, Acute metabolism, Leukemia, Myeloid, Acute pathology, Leukemia, Myeloid, Acute therapy, Mitochondrial Dynamics, Dynamins genetics, Dynamins metabolism, Mitochondrial Proteins genetics, Mitochondrial Proteins metabolism, GTP Phosphohydrolases genetics, GTP Phosphohydrolases metabolism, Oxidative Phosphorylation
- Abstract
Acute myeloid leukemia (AML) cells are highly dependent on oxidative phosphorylation and the mitochondrial dynamics regulated by fusion-related genes MFN1, MFN2, and OPA1 and fission-related genes DNM1L and MFF. An analysis of previously published gene expression datasets showed that high expression of MFF was significantly associated with poor prognosis in patients with AML. Based on this finding, we investigated the impact of mitochondrial dynamics in AML. Transduction of shRNA against fission-related genes, DNM1L and MFF, inhibited growth and increased the mitochondrial area in AML cell lines. Extracellular flux analysis showed that deletion of mitochondrial dynamic regulators reduced mitochondrial respiration without significantly affecting glycolysis, except in shDNM1L-transfected cells. Immunodeficient NOG mice transplanted with DNM1L- or MFF-knockdown AML cells survived significantly longer than controls. Treatment of AML cell lines with Mdivi-1, which inhibits the DRP1 encoded by DNM1L, inhibited cell proliferation and oxidative phosphorylation. Our results show that mitochondrial dynamics play an important role in AML, and provide novel biological insights. The inhibition of mitochondrial dynamics induces unique mitochondrial alterations, which may be explored as a potential therapeutic target in AML., (© 2024. Japanese Society of Hematology.)
- Published
- 2024
- Full Text
- View/download PDF